NSE filing, NSE: PAUSHAKLTD. Summary written from the filing by ALFA Finder's alert engine.
Paushak Ltd: key numbers
- Share price
- ₹609.25
- Market cap
- ₹1,502 Cr
- Revenue (annual)
- ₹218.6 Cr
- Net profit (annual)
- ₹39.33 Cr
- P/E (TTM)
- 31.8×Sector 34.5×
- Promoter holding
- 67.28%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Paushak Ltd
All →Paushak Q2 FY27 Results: Net Profit ₹13.5 Cr, Up 57.0% YoY
Paushak Ltd reported revenue from operations of ₹89.3 Cr (+51.9% YoY) and net profit of ₹13.5 Cr (+57.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹13.5 Cr · +57.0% YoY
Paushak Other Announcement
Paushak Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026. This is a routine compliance disclosure.
Paushak Board Meeting Date
Paushak Ltd informed BSE and NSE that its Board will meet on 16 October 2026 to consider unaudited financial results for Q1 and H1 FY2026-27.
Paushak Other Announcement
The company submitted the mandatory quarterly certificate under Regulation 74(5) for the quarter ended September 30, 2026, confirming the processing of dematerialization requests.
Paushak Annual General Meeting
Paushak Limited declared the voting results for its 53rd Annual General Meeting. Shareholders approved the financial statements, dividend declaration, and director appointments.
Paushak Q1 FY27 Results: Net Profit ₹15.1 Cr, Up 25.8% YoY
Paushak Ltd reported revenue from operations of ₹83.5 Cr (+49.4% YoY) and net profit of ₹15.1 Cr (+25.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹15.1 Cr · +25.8% YoY
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.